MOREPENLAB

The stock has been placed in Additional Surveillance Measure (ASM) list LTASM - IV (16).

Morepen Laboratories Ltd.

NSE: MOREPENLAB

BSE: 500288

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

128.33+6.5 (+5.36%)

14 Oct, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

31.8 / 100

Value Score

21.2 / 100

Price Momentum Score

95.1 / 100

QVM Score

45.3 / 100

Key Metrics

Market Cap

7031.89

P/E (TTM)

50.04

P/B

5.64

P/S (TTM)

3.61

EV/EBITDA

38.97

CAPE (5Y)

71.28

ROE (TTM)

7.90

ROCE (TTM)

6.49

ROA (TTM)

5.11

Avg 3Y ROE

10.57

Earnings 3Y CAGR

39.20

Sales 3Y CAGR

8.76

Sales 5Y CAGR

8.17

Debt/Equity

0.17

Consensus TP

Strong Buy %

Promoter Holding

35.65

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Morepen Laboratories Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 95.1 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

95.1 / 100

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 50.15% for 12-month ended 30 Jun 2026 and the growth was 42.7 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.17 as on 30 Jun 2026 and Debt to Equity increased marginally by 0.08 in the last 1 year

What is Debt to Equity?

Negative

Expensive and at a premium to industry median P/E

PE TTM of 50.04 indicates that the stock is expensive on a standalone basis and is at a 58.3% premium to industry median P/E

What is P/E Ratio?

Median: 31.61

Value 50.04

-0.8705.79

Low and declining ROE

The company reported low ROE of 7.9% for 12-month ended 30 Jun 2026 and ROE declined by -388 bps from 1 year ago

What is ROE (FY)?

Low but stable operating margin

The company reported low operating margin of 7.6% for 12-month ended 30 Jun 2026 and operating margin improved marginally by 117 bps from 1 year ago

What is Operating profit margin?

Low revenue growth and in line with median growth of industry

The company delivered low revenue growth of 9.48% for 12-month ended 30 Jun 2026 and the growth was 1.2 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 10.68

Value 9.48

-99.6111701.8

Low dividend yield

The company has a low dividend yield of 0.16%

What is Dividend yield?

Neutral

Company's earnings are of moderate quality

Earnings quality score of 41.0 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

41.0 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Morepen Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Morepen Laboratories Ltd. Shareholding Pattern

Quarterly breakdown of Morepen Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Total Promoter	34.54	34.54	34.54	34.54	34.54	34.54	34.54	34.54	38.38	36.74	38.22	38.22	38.22	38.22	38.22	38.22	38.22	38.22	35.65	35.65	35.65	35.65	35.65	35.65	35.65	35.65	35.65
Indian Promoter	34.54	34.54	34.54	34.54	34.54	34.54	34.54	34.54	38.38	36.74	38.22	38.22	38.22	38.22	38.22	38.22	38.22	38.22	35.65	35.65	35.65	35.65	35.65	35.65	35.65	35.65	35.65
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	14.55	14.70	5.67	5.00	3.57	2.73	2.12	2.07	2.03	5.03	5.14	4.63	3.90	3.34	3.58	4.33	4.01	3.82	3.79	3.87	3.62	3.24	3.13	2.88	2.84	2.75	5.10
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	0.00	-	-	-	0.05	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	5.25	5.32	4.85	4.24	2.88	2.03	1.26	1.16	1.07	4.08	3.98	3.74	2.93	2.04	2.22	2.21	2.15	2.14	1.62	1.62	1.62	1.50	1.49	1.25	1.25	1.25	1.12
Govt	-	-	-	-	-	-	-	-	-	-	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
FII	0.74	0.82	0.82	0.76	0.68	0.68	0.86	0.91	0.96	0.95	1.15	0.89	0.96	1.00	1.29	2.11	1.85	1.67	2.08	2.22	1.94	1.72	1.62	1.62	1.58	1.46	3.43
Other Institutions	8.57	8.57	0.00	0.00	0.00	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.28	0.00	0.00	0.00	0.00	0.07	0.02	0.05	0.00	0.00	0.00	0.00	0.03	0.53
Non-Institution	50.91	50.76	59.79	60.46	61.89	62.73	63.34	63.39	59.59	58.24	56.63	57.14	57.88	58.44	58.20	57.44	57.77	57.96	60.56	60.47	60.72	61.11	61.21	61.46	61.50	61.59	59.24
Bodies Corporate	3.80	3.84	3.03	3.44	3.72	4.06	2.86	2.48	2.31	2.58	3.25	2.21	2.66	2.55	3.27	3.70	3.43	3.42	3.47	2.46	2.41	2.27	1.89	1.84	2.05	2.19	3.26
Others (incl. Retail) No. of shareholders	47.11 1,29,453	46.92 1,51,645	56.76 1,50,457	57.02 1,52,860	58.17 1,65,102	58.67 2,29,963	60.48 2,44,301	60.91 2,54,535	57.28 2,60,822	55.66 2,86,505	53.38 2,89,769	54.93 3,05,441	55.22 3,05,570	55.89 3,01,229	54.93 3,03,386	53.74 3,03,619	54.34 3,35,388	54.54 3,48,107	57.09 4,30,100	58.01 4,47,489	58.31 4,68,031	58.84 4,60,380	59.32 4,61,043	59.62 4,52,359	59.45 4,46,520	59.40 4,34,098	55.98 4,02,988

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Morepen Laboratories Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Liquid Holdings Private Limited Promoter Group	September-2022	Conversion of security (Acquisition) 22nd Sep 2022	0.00 %	₹ 25.00	50.00 lac	₹ 12.50 cr
React Investments and Financial Services Private Limited Promoter Group	September-2022	Conversion of security (Acquisition) 22nd Sep 2022	2.29 %	₹ 25.00	35.00 lac	₹ 8.75 cr
Mid-Med Financial Services and Investments Private Limited Promoter Group	September-2022	Conversion of security (Acquisition) 22nd Sep 2022	2.30 %	₹ 25.00	35.00 lac	₹ 8.75 cr
Concept Credits and Consultants Private Limited Promoter Group	April-2022	Conversion of security (Acquisition) 5th Apr 2022	2.63 %	₹ 25.00	35.00 lac	₹ 8.75 cr
Epitome Holdings Private Limited Promoter Group	April-2022	Conversion of security (Acquisition) 5th Apr 2022	2.45 %	₹ 25.00	35.00 lac	₹ 8.75 cr
Scope Credits and Financial Services Private Limited Promoter Group	April-2022	Conversion of security (Acquisition) 5th Apr 2022	2.68 %	₹ 25.00	35.00 lac	₹ 8.75 cr
Seed Securities and Services Private Limited Promoter Group	April-2022	Conversion of security (Acquisition) 5th Apr 2022	2.41 %	₹ 25.00	35.00 lac	₹ 8.75 cr
Solace Investments and Financial Services Private Limited Promoter Group	April-2022	Conversion of security (Acquisition) 5th Apr 2022	2.58 %	₹ 25.00	35.00 lac	₹ 8.75 cr
Solitary Investments and Financial Services Private Limited Promoter Group	April-2022	Conversion of security (Acquisition) 5th Apr 2022	2.58 %	₹ 25.00	35.00 lac	₹ 8.75 cr
Square Investments and Financial Services Private Limited Promoter Group	April-2022	Conversion of security (Acquisition) 5th Apr 2022	2.36 %	₹ 25.00	35.00 lac	₹ 8.75 cr

Corporate Actions

History of Morepen Laboratories Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 0.20/share
Record date: 19th Sep 2026Ex-date: 18th Sep 2026
Announced on: 26th May 2026
Dividend₹ 0.20/share
Record date: 30th Aug 2025Ex-date: 29th Aug 2025
Announced on: 12th May 2025
Dividend₹ 0.60/share
Record date: 23rd Sep 2002Ex-date: 18th Sep 2002
Announced on: 1st Jul 2002
Dividend₹ 0.20/share
Record date: 16th Sep 2001Ex-date: 5th Sep 2001
Announced on: 16th Jun 2001
Dividend₹ 0.50/share
Record date: 9th Feb 2001Ex-date: 23rd Jan 2001
Announced on: 16th Jan 2001

Company Profile

Overview of Morepen Laboratories Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Morepen Laboratories Limited is a pharmaceutical company. The Company is in the business of manufacturing, producing, developing and marketing a range of active pharmaceutical ingredients (APIs), branded and generic formulations and also home health products. Its APIs include Apixaban, Edoxaban, Lin...

Key personnel

Mr. Ajay Kumar Sharma

Chief Financial Officer

Mr. Vipul Kumar Srivastava

Compliance Officer, Company Secretary

Mr. Sanjay Suri

Managing Director

Mr. Sushil SuriD

Executive Chairman of the Board, Managing Director

Mrs. SavitaD

Non-Executive Independent Director

Mr. Praveen Kumar DuttD

Non-Executive Independent Director

Mr. Sharad JainD

Non-Executive Independent Director

Mr. Ranjit KhattarD

Non-Executive Independent Director

Incorporated on

01 Dec 1984

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

1,919

IPO date

16 Nov 1992

Free Float

31,40,52,111

Website

https://www.morepen.com/

Phone no.

+911244892000

Address

2nd Floor, Tower-C, DLF Cyber Park, Udyog Vihar III, Sector 20,, GURGAON, 122016, India

Frequently Asked Questions

What is the current share price of Morepen Laboratories Ltd.?

The current share price of Morepen Laboratories Ltd. is ₹ 128.33 as of 14 Oct 2026.

What is the market capitalisation of Morepen Laboratories Ltd.?

The market capitalisation of Morepen Laboratories Ltd. stands at ₹ 7,031.89 Cr.

What is the PE ratio of Morepen Laboratories Ltd.?

The Price-to-Earnings (PE) ratio of Morepen Laboratories Ltd. is 50.04 as of the latest trailing twelve months data.

What is the ROE and ROCE of Morepen Laboratories Ltd.?

Morepen Laboratories Ltd. has a Return on Equity (ROE) of 7.90% and a Return on Capital Employed (ROCE) of 6.49% as per the latest financial reports.

What is the 52-week high and low of Morepen Laboratories Ltd.?

The 52-week high of Morepen Laboratories Ltd. is - and the 52-week low is -.

What is the dividend yield of Morepen Laboratories Ltd.?

The dividend yield of Morepen Laboratories Ltd. is 0.16% based on the current market price.

What is the FII and DII holding in Morepen Laboratories Ltd.?

Foreign Institutional Investors (FII) hold 3.43%, Domestic Institutional Investors (DII) hold 1.12% and retail/public investors hold 55.98% of Morepen Laboratories Ltd. shares.

What sector does Morepen Laboratories Ltd. belong to?

Morepen Laboratories Ltd. operates in the Healthcare sector.

What is the beta of Morepen Laboratories Ltd.?

The beta of Morepen Laboratories Ltd. is 1.45, indicating its price volatility relative to the broader market. Over the past 1 year, Morepen Laboratories Ltd. has delivered an absolute return of 164.65%.

What is the RSI of Morepen Laboratories Ltd.?

The 14-day Relative Strength Index (RSI) of Morepen Laboratories Ltd. is 55.42, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Morepen Laboratories Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Morepen Laboratories Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile